PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations.

Marius E MayerhoeferHelmut ProschLucian BeerDietmar TamandlThomas BeyerChristoph HoellerDominik BerzaczyMarkus RadererMatthias PreusserMaximilian HochmairBarbara KiesewetterChristian ScheubaAhmed Ba-SsalamahGeorgios KaranikasJulia KesselbacherGerald PragerKarin DieckmannStephan PolterauerMichael WeberIvo RauschBernhard BraunerHarald EidherrWolfgang WadsakAlexander R Haug

Published in: European journal of nuclear medicine and molecular imaging (2019)

PET/MRI enables more appropriate management than PET/CT in a nonnegligible fraction of cancer patients. Since the per-examination cost is about 50% higher for PET/MRI than for PET/CT, a histology-based triage of patients to either PET/MRI or PET/CT may be meaningful.

Keyphrases

pet ct
contrast enhanced
magnetic resonance imaging
positron emission tomography
end stage renal disease
emergency department
computed tomography
chronic kidney disease
ejection fraction
magnetic resonance
prognostic factors
peritoneal dialysis
case report
patient reported outcomes
patient reported